BackEquillium Overview
Equillium Inc

Equillium Target Price

Analysts' average 12-month price target for Equillium is $6.3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.01

Average Target Price

$6.25210.9% upside

4 analysts in the last 4 months

High: $7 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-28Raymond James$7248.3% upsideOpen
2026-05-28Stifel NicolausAlex Thompson$5148.8% upsideOpen
2026-05-28Leerink PartnersThomas Smith$6198.5% upsideOpen
2026-04-23Oppenheimer$7248.3% upsideOpen
2026-04-13Raymond James$6198.5% upsideOpen
2025-03-28Leerink PartnersThomas Smith$150.2% downsideOpen

Equillium (EQ) FAQ

Equillium (EQ) currently reports a target price of $6.3. Use the charts on this page to explore Equillium's target price history and peer comparisons.

Analysts' average 12-month price target for Equillium is $6.3, about 210.9% upside from the current share price of $2.01. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $6.3, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Equillium, and consider following EQ for alerts when major investors trade the stock.

Equillium is classified in the Healthcare sector. On target price, it currently shows $6.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EQ with unrelated industries.